Managing The Functional Side of Psychedelics presented by Dr. Jack Allocca

The way we do work is being shaped by unprecedented exponential technologies, a global competitive landscape and constant disruptive innovation, and certain hard limits are starting to manifest at the level of biology. Generations of workers have overridden many of their limitations with coffee alone, but this measure is starting to become inadequate. Those at the top of the business food chain are facing unparalleled cognitive requirements to ensure innovation and performance.

This has sparked a race for novel and often poorly tested enhancing tools, from folk remedies to prescription stimulants, all the way to experimental compounds. In a world desperate for the next hot thing, some have decided to look backwards in the direction of psychedelic compounds. Prior to their widespread ban in the 60’s, many of these substances had been used to enhance and manipulate certain aspects of the mind.

Fast forward to now. Performance-hungry innovators have turned to psychedelics to walk the leading edge. Their powers are immense and have been validated in several contexts; however, their illegal status has slowed the pace at which they are proven in the lab. Recent de-regulation and de-criminalization of psychedelics have rushed a rapid experimentation amongst business leaders worldwide, both with notable successes and failures.

During this session, Dr. Jack Allocca will present:

• The latest in science around where we are at when it comes to managing the functional side of psychedelics with a focus on microdosing
• Insights from over a decade in the trenches of underground self-experimentation that Dr. Allocca has pursued during his career and personal life

This session is not to condone or encourage under current legal regulations, but to present some of the key aspects to minimize the harm and maximize the benefits.

All attendees will be required to sign an NDA prior to the presentation. Please RSVP to melissa.groen@arizonaeo.com.